Assembly Biosciences's market cap is currently $399.27M. The company's EPS TTM is $-1.33; its P/E ratio is ―; Assembly Biosciences is scheduled to report earnings on August 6, 2025, and the estimated EPS forecast is $-0.82. See an overview of income statement, balance sheet, and cash flow financials.
